SL Science Holding Ltd（SLBT）資訊與事件

$2.790

+0.061 (+2.20%)收盤時

SLBT 資訊

SL Science Holding Files New Drug Master File with FDA

SL Science Files New Drug Master File with FDA

Biotech Stocks Surge with Significant Gains

SL Science Showcases γδ T Cell Therapy for Glioblastoma

SL Science Submits Orphan Drug Designation for Brain Cancer Treatment

SL Science Holding Submits Orphan Drug Designation for GBM Therapy

Biotech Companies See Significant Stock Gains

SL Science Reports 2025 Financial Results and Strategic Shift

Biotech Companies Achieve Significant Milestones

Biotech Stocks Show Significant Pre-Market Activity

本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。